AzTrials
AzTrials

Enteral FeedingNCT01665664

Hypocaloric vs. Full Energy Enteral Feeding in Critically Ill Patients

A study testing Hypocaloric feeding in people with Enteral Feeding, run by Wolfson Medical Center at 1 site in Israel.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Underfeeding in the critically ill patient is a common observable fact throughout intensive care units. Patients who develop caloric deficit during their stay in the ICU have been shown in previous reports to be associated with increased complications such as increased rate of infections, and nosocomial blood stream… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Enteral Feeding
What is being tested?
Hypocaloric feeding
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteIsrael
Study dates
Sep 2012to Oct 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Anticipated Mechanical ventilation for at least 72 hrs.
  • Need for enteral feeding
  • men and woman aged 18 or older.

Who cannot join

  • Abdominal surgery with inability to feed enterally.
  • FiO2 greater than 80%
  • Bronchopleural fistula
  • Hemodynamic instability in spite the use of vassopressors.

Trial locations and contacts

1 site in 1 country.

Arie Soroksky, M.D. contact

972-50-4056787

soroksky@gmail.com

Israel1 site
  • Wolfson MC

    Holon, 58100

    Arie Soroksky, MD, 972-50-4056787, soroksky@gmail.com

    Arie Soroksky, MD

Other trials in Israel

About this study

Official title: Hypocaloric vs. Full Energy Enteral Feeding in Critically Ill Patients Guided by Indirect Calorimetry, a Prospective, Blinded, Randomized Controlled Trial.

Underfeeding in the critically ill patient is a common observable fact throughout intensive care units. Patients who develop caloric deficit during their stay in the ICU have been shown in previous reports to be associated with increased complications such as increased rate of infections, and nosocomial blood stream infections. Yet, other studies have shown that patients with moderate caloric deficit may be associated with better outcome than patients who receive higher levels of caloric intake.

Read the detailed description

Therefore, the aim of our study is to establish the exact amount of calories to be delivered by indirect calorimetry individually for each patient. Thereafter, each patient will be randomized to the trophic group (hypocaloric feeding), or to the full energy delivery group.

Conditions
Enteral Feeding
Being tested
Hypocaloric feeding
Keywords
Indirect calorimetry, hypocaloric feeding

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hypocaloric feedingOther

    Also called trophic group

    Daily calorimetry for the first 6 days will be performed with determination of REE and the required amount of calories needed for the next 24 hours. In this group only 20% of REE will be provided but not less than 300 kcal/day.

Study groups in NCT01665664
Study groupRoleWhat they receive
Hypocaloric feeding groupOtherintervention - Daily calorimetry for the first 6 days will be performed with determination of REE and the required amount of calories needed for the next 24 hours. In this group only 20% of REE will be provided but not less than 300 kcal/day.
Receives: Other: Hypocaloric feeding
Full energy feeding groupNo interventionDaily calorimetry for the first 6 days will be performed with determination of REE and the required amount of calories needed for the next 24 hours. In this group only 100% of REE will be provided.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. All cause mortality, ICU mortality, Hospital mortality.

    All cause mortality, ICU mortality, Hospital mortality.

    Measured: 1 year

Secondary outcomes (1)
  1. ICU and Hospital LOS, Length of mechanical ventilation, rate of infections,

    ICU LOS, Hospital LOS, Length of mechanical ventilation, ventilation free days, rate of infections, rate of ventilator associated pneumonia,

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Aug 2012 (estimated)
  2. Study startSep 2012
  3. Primary completionSep 2013 (estimated)
  4. Study completionOct 2013 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01665664
Sponsor's protocol ID
0014-12-WOMC
Status last verified
Aug 2012
First submitted
13 Aug 2012
Last updated
15 Aug 2012
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Hypocaloric feeding in people with Enteral Feeding, run by Wolfson Medical Center at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Aug 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Arie Soroksky, M.D. (972-50-4056787, soroksky@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

All cause mortality, ICU mortality, Hospital mortality. (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Aug 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in